Travere Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 6.5 | 5.5 | 5.2 | 5.3 | 6.4 | 5.5 | 5.6 | 6.7 | 7.2 | 5.7 | 5.7 | 5.0 | 2.9 | 3.5 | 3.5 | 4.9 | 4.9 | 7.1 | 7.1 | 4.3 | 6.7 | 8.4 | 7.1 | 6.8 | 8.4 | 7.2 | 7.9 | 6.8 | 3.7 | 4.0 | 3.8 | 3.6 | 5.4 | 6.2 | 5.8 | 3.9 | 5.6 | 7.0 | 5.1 | 9.0 | |
| 2.7 | 2.4 | 2.4 | 2.6 | 3.2 | 2.9 | 3.0 | 3.8 | 3.7 | 2.9 | 3.3 | 3.0 | 2.0 | 2.8 | 2.8 | 2.9 | 3.1 | 6.6 | 3.9 | 2.7 | 4.8 | 6.3 | 7.8 | 9.8 | 15.6 | 31.5 | 8.1 | 10.0 | 2.4 | 3.4 | 8.0 | 42.0 | – | 24.5 | 48.2 | 40.2 | 33.3 | 30.0 | 27.6 | 216.5 | |
| – | 5.4 | – | – | – | – | – | 6.5 | 6.4 | 5.2 | 5.4 | – | – | – | 4.2 | 4.7 | 4.9 | 10.2 | 7.5 | 5.0 | 7.3 | 8.7 | 7.7 | 7.6 | 9.6 | 8.9 | 9.0 | 8.6 | 5.0 | 5.9 | 6.0 | 5.6 | 7.1 | 7.6 | 7.0 | 4.9 | 6.1 | 7.5 | 5.5 | 9.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 165.3 | 77.0 | 1,004.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 510.2 | – | 103.1 | |
| -0.8% | -1.8% | -2.0% | -1.8% | -1.4% | -0.8% | -2.5% | -2.9% | -3.5% | -4.8% | -4.9% | -7.4% | -14.6% | -11.3% | -12.4% | -7.4% | -5.2% | -11.6% | -11.7% | -17.1% | -8.1% | -1.8% | -3.6% | -6.3% | -10.7% | -14.2% | -15.7% | -23.6% | -43.5% | -46.0% | -56.1% | -49.2% | -28.0% | -18.9% | -12.8% | -11.0% | -3.3% | 0.2% | -0.1% | 1.0% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 96.8% | 96.6% | 96.7% | 97.0% | 97.6% | 97.7% | 97.2% | 97.0% | 96.9% | 96.6% | 97.0% | 97.2% | 97.0% | 94.0% | 94.1% | 93.9% | 94.3% | 96.9% | 96.8% | 96.8% | 96.9% | 97.0% | 96.8% | 96.6% | 92.9% | 92.9% | 91.7% | 91.0% | 94.7% | 85.8% | 86.7% | 82.2% | 84.3% | 92.2% | 92.2% | 96.9% | 97.6% | 97.9% | 94.0% | 94.4% | |
| -43.6% | -43.6% | -46.6% | -46.3% | -37.9% | -34.7% | -35.9% | -40.2% | -55.5% | -48.7% | -60.7% | -68.3% | -66.2% | -73.1% | -57.2% | -48.9% | -39.5% | -88.8% | -105.4% | -108.2% | -105.4% | -71.1% | -74.9% | -88.3% | -134.2% | -145.7% | -151.3% | -192.7% | -188.7% | -209.9% | -268.8% | -214.9% | -169.7% | -138.6% | -82.8% | -51.6% | -20.9% | -12.8% | -10.6% | -6.8% | |
| -33.0% | -35.9% | -50.8% | -48.7% | -33.8% | -38.6% | -42.0% | -46.9% | -69.4% | -62.5% | -75.7% | -83.9% | -71.7% | -83.5% | -57.0% | -49.1% | -40.2% | -85.4% | -113.2% | -116.1% | -113.1% | -79.2% | -88.5% | -100.9% | -140.6% | -149.2% | -148.0% | -177.6% | -47.8% | -65.0% | -103.5% | -82.1% | -172.7% | -137.9% | -82.9% | -50.6% | -20.3% | -5.2% | -4.0% | -7.4% | |
| -5.4% | -10.1% | -10.5% | -9.6% | -9.2% | -4.3% | -14.1% | -19.3% | -25.2% | -27.2% | -27.9% | -36.8% | -42.2% | -39.8% | -43.0% | -36.0% | -25.4% | -82.0% | -83.1% | -74.2% | -54.1% | -14.9% | -25.7% | -42.9% | -89.9% | -102.7% | -123.1% | -159.3% | -162.2% | -184.9% | -213.9% | -176.1% | -149.6% | -117.4% | -73.9% | -43.5% | -18.4% | 1.4% | -0.3% | 8.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -13.6% | -15.6% | -23.3% | -23.7% | -16.7% | -20.4% | -22.4% | -26.4% | -35.4% | -32.3% | -43.8% | -51.1% | -50.3% | -66.2% | -46.4% | -28.9% | -25.9% | -80.2% | -61.8% | -71.3% | -81.4% | -59.6% | -97.1% | -146.9% | -262.5% | -649.9% | -152.7% | -263.9% | -31.1% | -55.5% | -217.5% | -963.3% | – | -544.3% | -690.7% | -516.2% | -120.4% | -22.2% | -21.7% | -177.2% | |
| -7.8% | -9.1% | -13.8% | -13.8% | -9.7% | -11.5% | -13.4% | -15.5% | -15.8% | -14.5% | -18.8% | -21.9% | -20.1% | -24.2% | -18.3% | -13.6% | -11.3% | -27.9% | -29.3% | -31.7% | -32.3% | -23.2% | -24.4% | -29.5% | -36.4% | -41.4% | -35.7% | -41.7% | -10.5% | -14.1% | -24.3% | -26.5% | -69.7% | -54.1% | -41.3% | -30.4% | -16.4% | -4.2% | -3.9% | -5.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | -14 | – | – | – | – | – | -44 | -132 | -80 | -47 | – | – | – | 140 | -27 | 13 | 623 | 71 | 140 | 137 | 65 | 122 | 199 | 228 | 318 | 219 | 310 | 237 | 324 | 339 | 351 | 347 | 326 | 323 | 310 | 206 | 225 | 240 | 491 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.1 | 6.2 | 85.0 | |
| 57.8% | 58.6% | 59.0% | 58.3% | 58.5% | 56.3% | 59.8% | 58.6% | 44.6% | 44.9% | 42.8% | 42.8% | 40.1% | 36.6% | 39.4% | 46.9% | 43.5% | 34.8% | 47.5% | 44.5% | 39.7% | 38.9% | 25.1% | 20.1% | 13.9% | 6.4% | 23.4% | 15.8% | 33.6% | 25.5% | 11.2% | 2.7% | -6.0% | 9.9% | 6.0% | 5.9% | 13.7% | 19.0% | 17.8% | 3.1% | |
| – | 0.1 | – | – | – | – | – | 0.2 | 0.1 | 0.1 | 0.1 | – | – | – | 0.9 | 0.7 | 0.7 | 3.3 | 0.6 | 0.7 | 0.9 | 0.8 | 1.8 | 2.4 | 3.8 | 8.9 | 2.0 | 3.3 | 1.4 | 1.9 | 5.2 | 25.3 | – | 6.5 | 11.7 | 11.8 | 4.3 | 2.8 | 3.2 | 24.8 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.13 | -1.22 | -1.79 | -1.79 | -1.31 | -1.49 | -1.69 | -1.90 | -2.77 | -2.49 | -3.03 | -3.38 | -2.88 | -3.36 | -2.40 | -2.06 | -1.53 | -3.31 | -3.98 | -3.91 | -4.11 | -2.92 | -3.20 | -3.62 | -4.13 | -4.34 | -4.24 | -4.05 | -1.14 | -1.46 | -2.09 | -1.88 | -4.52 | -3.87 | -2.57 | -1.90 | -0.86 | -0.28 | -0.23 | -0.46 | |
| 3.43 | 3.41 | 3.53 | 3.68 | 3.88 | 3.86 | 4.03 | 4.05 | 3.99 | 3.98 | 3.99 | 4.02 | 4.02 | 4.02 | 4.21 | 4.18 | 3.81 | 3.87 | 3.52 | 3.37 | 3.64 | 3.69 | 3.62 | 3.58 | 2.94 | 2.91 | 2.86 | 2.28 | 2.39 | 2.24 | 2.02 | 2.29 | 2.62 | 2.81 | 3.10 | 3.75 | 4.25 | 5.43 | 5.84 | 6.33 | |
| 8.32 | 7.86 | 7.68 | 7.58 | 7.88 | 7.31 | 7.55 | 7.19 | 7.84 | 7.71 | 6.90 | 6.60 | 5.73 | 5.07 | 5.18 | 7.12 | 5.92 | 4.12 | 6.45 | 5.49 | 5.06 | 4.90 | 3.30 | 2.46 | 1.57 | 0.67 | 2.77 | 1.53 | 3.67 | 2.63 | 0.96 | 0.20 | -0.39 | 0.71 | 0.37 | 0.37 | 0.72 | 1.27 | 1.07 | 0.26 | |
| -0.18 | -0.35 | -0.37 | -0.35 | -0.36 | -0.16 | -0.57 | -0.78 | -1.01 | -1.08 | -1.11 | -1.48 | -1.69 | -1.60 | -1.81 | -1.51 | -0.97 | -3.17 | -2.92 | -2.50 | -1.97 | -0.55 | -0.93 | -1.54 | -2.64 | -2.98 | -3.52 | -3.63 | -3.87 | -4.14 | -4.32 | -4.04 | -3.91 | -3.29 | -2.29 | -1.63 | -0.78 | 0.07 | -0.02 | 0.55 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.